- €315.91m
- €302.02m
- €288.13m
- 83
- 57
- 59
- 78
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 213 | 213 | 215 | 272 | 288 |
Cost of Revenue | |||||
Gross Profit | 201 | 203 | 203 | 246 | 259 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 194 | 144 | 195 | 155 | 266 |
Operating Profit | 19 | 68.8 | 19.1 | 118 | 21.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 18.4 | 57.1 | 21.5 | 112 | 26.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13.5 | 53.4 | 17.9 | 110 | 23.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 13.2 | 53.3 | 17.7 | 110 | 22.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 13.2 | 53.3 | 17.7 | 110 | 22.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.48 | 0.871 | 2.15 | 2.23 | 2.89 |
Dividends per Share | |||||
Special Dividends per Share |